ETF Components for PJP - PowerShares Dynamic Pharmaceuticals


Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

Holdings

Symbol Grade Price % Change Allocation
LLY B -0.95 6.38
REGN B -1.97 6.27
ABBV C -1.28 6.26
AMGN B -0.45 6.06
MRK C -1.46 6.01
ABT D -0.84 5.90
JNJ F -0.23 5.81
PFE D -0.47 5.64
GERN C 4.56 4.77
UTHR B -1.90 4.19
PBH C -1.41 3.87
GILD C -2.65 3.85
INVA B -1.03 3.67
JAZZ F -1.48 3.64
BIIB C -1.84 3.61
ANIP D -2.91 3.59
SUPN F 0.93 3.46
AMPH F 2.61 3.42
CORT C -3.36 3.40
PCRX F -4.75 3.34
PRGO D 0.77 3.31
LGND B -2.46 3.25

Recent News for PowerShares Dynamic Pharmaceuticals & its Holdings

Date Stock Title
Jul 3 ABBV AbbVie Q2 IPR&D expenses to lower EPS by $0.52
Jul 3 PCRX Pacira downgraded at Barclays following generic Exparel approval
Jul 3 LLY Lilly's new Alzheimer's drug could generate $7.1B in sales: analyst
Jul 3 AMGN S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
Jul 3 LLY S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
Jul 3 BIIB Top Stock Movers Now: Tesla, Paramount Global, Biogen, and More
Jul 3 LLY Novo Nordisk, Eli Lilly Tumble After Study Suggests Weight-Loss Drugs Can Lead To Blindness
Jul 3 LLY Weight-loss drugs linked to rare vision loss: Harvard study
Jul 3 LLY ADP jobs data, Constellation Brands, summer gas prices: Morning Brief
Jul 3 LLY Ozempic Linked to Rare Cases of Vision Loss in Harvard Study
Jul 3 LLY FDA Approves Eli Lilly's Alzheimer's Drug Kisunla
Jul 3 BIIB Biogen completes $1.15bn HI-Bio acquisition to expand immunology presence
Jul 3 MRK Merck: Among The Best Health Care GARP Plays Today
Jul 3 PFE GSK Will Pay Up to $1.5 Billion for CureVac’s mRNA Vaccines
Jul 3 JNJ Johnson & Johnson: A Lot Of Moving Parts, But Perhaps Finally Lurching In The Right Direction
Jul 3 JNJ Johnson & Johnson: Put Selling Can Yield A Potential 9.8% Return
Jul 3 LLY Top 3 Health Care Stocks That May Crash This Quarter
Jul 3 ABBV Company News for Jul 3, 2024
Jul 3 PFE Pfizer (PFE) Stock Falls in a Year: Time to Buy, Sell or Hold?
Jul 3 AMGN Health Care Stocks With A Long History Of Dividend Growth And Solid Yields
The PowerShares Dynamic Pharmaceuticals Portfolio (Fund) is based on the Dynamic Pharmaceutical IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including: price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US pharmaceuticals companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.
Exchange Traded Fund ETF Exchange Traded Funds Pharmaceutical Invesco Powershares Inter 10 Index
Back to the Main PJP Page...